… -induced skin toxicity and treatment efficacy, including a retrospective review of Cetuximab
with radiotherapy for Squamous Cell Carcinoma of Head and Neck that showed a better …

… /metastatic squamous cell carcinoma of the head and neck (R/M … Herein, the efficacy and
safety of paclitaxel and cetuximab … cetuximab for squamous cell carcinoma of head and neck. …

… cetuximab in patients with locoregionally advanced head and neck squamous cell
carcinoma (HNSCC; stage III-IV according to the Union for International Cancer Control TNM …

… We chose to have a cetuximab lead-in to exclude patients with cetuximab-related infusion
reaction. Patients having a cetuximab-related infusion reaction or who did not receive cycle 1 …

… Background: This was a double-blind, randomized phase 2 study of 96 patients with poor
prognosis locally advanced, squamous cell carcinoma of the head and neck (LASCCHN). …

Background To evaluate potential synergistic effect of pembrolizumab with radiotherapy (RT)
compared with a standard-of-care (SOC) cetuximab–RT in patients with locally advanced-…

… of cetuximab and nivolumab for toxicity and efficacy in patients with incurable recurrent
and/or metastatic head and neck squamous cell carcinoma (… effects of cetuximab and immune …

… Head and Neck Squamous Cell Cancers (LA-HNSCC). Many important phase-III clinical
trials were undertaken simultaneously, where the use of Cetuximab … success, Cetuximab has …

Background Induction chemotherapy (IC) in locally advanced squamous cell carcinoma of
the head and neck (LA‐SCCHN) often compromises compliance with subsequent …

… the combination platinum, taxanes, and cetuximab scheme as a first-line therapy for
patients with recurrent or metastatic squamous cell carcinoma of the head and neck in a real-world …